BioNTech SE
NASDAQ:BNTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
McDonald's Corp
NYSE:MCD
|
US |
|
M
|
Mitsubishi Kakoki Kaisha Ltd
TSE:6331
|
JP |
|
Avis Budget Group Inc
NASDAQ:CAR
|
US |
|
Heineken Holding NV
AEX:HEIO
|
NL |
|
Nexpoint Real Estate Finance Inc
NYSE:NREF
|
US |
|
Iron Mountain Inc
NYSE:IRM
|
US |
|
Ci&T Inc
NYSE:CINT
|
BR |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Shanghai Zhangjiang Hi-Tech Park Development Co Ltd
SSE:600895
|
CN |
|
COPT Defense Properties
NYSE:CDP
|
US |
|
C
|
CEL-SCI Corp
AMEX:CVM
|
US |
|
Engie SA
PAR:ENGI
|
FR |
|
3D Systems Corp
NYSE:DDD
|
US |
|
Roku Inc
NASDAQ:ROKU
|
US |
|
Pinelawn Cemetery
OTC:PLWN
|
US |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
|
P
|
Polygiene Group AB
STO:POLYG
|
SE |
|
UniCredit SpA
MIL:UCG
|
IT |
Wall St Price Targets
BNTX Price Targets Summary
BioNTech SE
According to Wall Street analysts, the average 1-year price target for
BNTX is 133.32 USD with a low forecast of 82.93 USD and a high forecast of 190.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BNTX's stock price target?
Price Target
133.32
USD
According to Wall Street analysts, the average 1-year price target for
BNTX is 133.32 USD with a low forecast of 82.93 USD and a high forecast of 190.05 USD.
What is the Revenue forecast for BioNTech SE?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 8%.